Non invasive assessment of liver steatosis and fibrosis in HIV/HCV and HCV infected patients
Texto completo
Figure
Documento similar
To identify viral factors associated with the HCV treatment response, we analyzed the pretreatment NS3/4A protease gene quasispecies composition of 56 HCV genotype
This study evaluated the usefulness of baseline FibroScan values for predicting SVR and the occurrence of anemia and other severe adverse events in HCV genotype 1 patients with
We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with peg-
Integrated HIV DNA was quantified by q-PCR in cross- sectional samples from different groups of patients: (1) HIV+ group: HIV-monoinfected patients that had never been in contact
A pool of Hdac6 +/+ and Hdac6 -/- spleens non-infected was used as a control sample without infection (NI). Control vehicles and autophagy markers. A) Total CFUs at 0 and 6 hpi in
We have evaluated the performance of a deep-sequencing-based HCV subtyping assay, developed for the 454/GS-Junior platform, in comparison with those of two commercial assays
In conclusion, the results of this study analyzing treatment outcomes for LDV/SOF against HCV genotype 1 in treatment- naïve noncirrhotic patients suggest that HIV infection is a
This analysis showed that levels of both exhaustion and activation of effector CD4 T-cells were significantly increased in pre-DAAs HIV/HCV patients compared to HIV patients,